Abstract
Intraoperative redosing of prophylactic antibiotics is recommended for prolonged surgical procedures, although its efficacy has not been assessed. We retrospectively compared the risk of surgical site infections in 1,548 patients who underwent cardiac surgery lasting >240 min after preoperative administration of cefazolin prophylaxis. The overall risk of surgical site infection was similar among patients with (43 [9.4%] of 459) and without (101 [9.3%] of 1,089) intraoperative redosing (odds ratio [OR] 1.01, 95% confidence interval [CI] 0.70-1.47). However, redosing was beneficial in procedures lasting >400 min: infection occurred in 14 (7.7%) of 182 patients with redosing and in 32 (16.0%) of 200 patients without (adjusted OR 0.44, 95% CI 0.23-0.86). Intraoperative redosing of cefazolin was associated with a 16% reduction in the overall risk for surgical site infection after cardiac surgery, including procedures lasting <240 min.
Full Text
The Full Text of this article is available as a PDF (35.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coppa G. F., Eng K. Factors involved in antibiotic selection in elective colon and rectal surgery. Surgery. 1988 Nov;104(5):853–858. [PubMed] [Google Scholar]
- Dellinger E. P., Gross P. A., Barrett T. L., Krause P. J., Martone W. J., McGowan J. E., Jr, Sweet R. L., Wenzel R. P. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis. 1994 Mar;18(3):422–427. doi: 10.1093/clinids/18.3.422. [DOI] [PubMed] [Google Scholar]
- Goldmann D. A., Hopkins C. C., Karchmer A. W., Abel R. M., McEnany M. T., Akins C., Buckley M. J., Moellering R. C., Jr Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg. 1977 Mar;73(3):470–479. [PubMed] [Google Scholar]
- Harbarth S., Samore M. H., Lichtenberg D., Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000 Jun 27;101(25):2916–2921. doi: 10.1161/01.cir.101.25.2916. [DOI] [PubMed] [Google Scholar]
- Kaiser A. B., Herrington J. L., Jr, Jacobs J. K., Mulherin J. L., Jr, Roach A. C., Sawyers J. L. Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations. Importance of the duration of the surgical procedure. Ann Surg. 1983 Oct;198(4):525–530. doi: 10.1097/00000658-198310000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- L'Ecuyer P. B., Murphy D., Little J. R., Fraser V. J. The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis. 1996 Mar;22(3):424–429. doi: 10.1093/clinids/22.3.424. [DOI] [PubMed] [Google Scholar]
- Maki D. G., Bohn M. J., Stolz S. M., Kroncke G. M., Acher C. W., Myerowitz P. D. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. J Thorac Cardiovasc Surg. 1992 Nov;104(5):1423–1434. [PubMed] [Google Scholar]
- Mangram A. J., Horan T. C., Pearson M. L., Silver L. C., Jarvis W. R. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999 Apr;20(4):250–280. doi: 10.1086/501620. [DOI] [PubMed] [Google Scholar]
- Martin C. Antimicrobial prophylaxis in surgery: general concepts and clinical guidelines. French Study Group on Antimicrobial Prophylaxis in Surgery, French Society of Anesthesia and Intensive Care. Infect Control Hosp Epidemiol. 1994 Jul;15(7):463–471. doi: 10.1086/646952. [DOI] [PubMed] [Google Scholar]
- Page C. P., Bohnen J. M., Fletcher J. R., McManus A. T., Solomkin J. S., Wittmann D. H. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg. 1993 Jan;128(1):79–88. doi: 10.1001/archsurg.1993.01420130087014. [DOI] [PubMed] [Google Scholar]
- Platt R., Muñoz A., Stella J., VanDevanter S., Koster J. K., Jr Antibiotic prophylaxis for cardiovascular surgery. Efficacy with coronary artery bypass. Ann Intern Med. 1984 Dec;101(6):770–774. doi: 10.7326/0003-4819-101-6-770. [DOI] [PubMed] [Google Scholar]
- Shapiro M., Muñoz A., Tager I. B., Schoenbaum S. C., Polk B. F. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med. 1982 Dec 30;307(27):1661–1666. doi: 10.1056/NEJM198212303072701. [DOI] [PubMed] [Google Scholar]